This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yamada, M. Articles by Mizusawa, H. Search for Related Content PubMed PubMed Citation Articles by Yamada, M. Articles by Mizusawa, H. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Amyloidosis

(Stroke. 1999;30:2277-2279.)
© 1999 American Heart Association, Inc.

Original Contributions

A Deletion Polymorphism of ₂-Macroglobulin Gene and Cerebral Amyloid Angiopathy

Masahito Yamada, MD, PhD; Nobuyuki Sodeyama, MD, PhD; Yoshinori Itoh, MD, PhD; Naomi Suematsu, MD, PhD; Eiichi Otomo, MD, PhD; Masaaki Matsushita, MD, PhD Hidehiro Mizusawa, MD, PhD

From the Department of Neurology, Tokyo Medical and Dental University (M.Y., N. Sodeyama, H.M.); the Departments of Internal Medicine (Y.I., E.O.) and Pathology (N. Suematsu), Yokufukai Geriatric Hospital; and the Department of Neuropathology, Tokyo Institute of Psychiatry (M.M.), Tokyo, Japan.

Correspondence to Dr Masahito Yamada, Department of Neurology, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. E-mail m-yamada.nuro{at}med.tmd.ac.jp

Background and Purpose—₂-Macroglobulin may be implicated in amyloid ß protein deposition. A deletion in the exon 18 splice acceptor of the ₂-macroglobulin gene (A2M) has been reported to be associated with risk for Alzheimer's disease (AD). In search of genetic risk factors for cerebral amyloid angiopathy (CAA), we investigated association of the A2M deletion polymorphism with CAA.

Methods—The association between the severity of CAA and A2M deletion polymorphism was investigated in 178 autopsy cases of the elderly including 68 patients with AD.

Results—There was no significant difference in the severity of CAA between individuals with the A2M deletion allele and those without in the AD, non-AD, or total cases. Status for the 4 allele of the apolipoprotein E gene did not influence the results.

Conclusions—Our results suggest that the A2M deletion polymorphism may not be a definitive risk factor of CAA in the elderly, although further study with larger samples is necessary to confirm this.

Key Words: Alzheimer's disease • amyloid • cerebrovascular disorders • polymorphism (genetics)